Risk time splitting for improved estimation of screening programs effect on later mortality
Harald Weedon-Fekj{\ae}r, Elsebeth Lynge, Niels Keiding

TL;DR
This paper refines and explains a statistical method for evaluating the impact of cancer screening programs on mortality, improving precision by utilizing all available data and applying maximum likelihood estimation.
Contribution
It provides a detailed explanation and enhancement of a novel estimation approach for screening effects, facilitating wider adoption and more precise analysis.
Findings
Bootstrap confidence intervals are narrower with the new method.
The method effectively estimates screening effects in Norwegian and Danish data.
Improved study precision over previous approaches.
Abstract
There is a great need for evaluating screening programs, but analysing data from population screening is often complicated by a delayed screening effect. In cancer screening, only new, not yet clinically diagnosed cases, might benefit from screening through earlier treatment. Hence, mortality data following screening should be analysed based on refined mortality, separating cases based on diagnosis before and after first screening invitation. Historically, refined mortality has been implemented by selecting comparison groups from the available data to disentangle the causal effect. While giving valid estimates, the ignorance of large parts of the available data has limited study precision. In BMJ 2014, Weedon-Fekj{\ae}r et al. used a new estimation approach applying all the available Norwegian mammography screening data. The estimation uses historic pre-screening data on time from…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGlobal Cancer Incidence and Screening · Colorectal Cancer Screening and Detection · Health Promotion and Cardiovascular Prevention
